URL Biolinks
Logical relations between drugs, symptoms, etc.
Logical relations between drugs, symptoms, etc.
Filtering medical statements by publication URL
From this research we know that
-
2012
-
Huperzine A can significantly improve the cognitive function in patients with mild to moderate vascular dementia. Further, the medicament is safe.
-
-
Comments:
«The increase in MMSE score became statistically significant after 8 and 12 weeks of treatment (P < 0.01). By contrast, patients in control group did not show any such changes in MMSE scores (P > 0.05).»
«After 8 and 12 weeks of treatment, CDR scores in the treatment group decreased significantly (P < 0.01). By contrast, CDR scores in control group did not change significantly during the entire course of treatment (P > 0.05).»
«ADL score significantly decreased after 8 and 12 weeks of treatment with Huperzine A (P < 0.01). Furthermore, these changes were also significantly different compared to control group (P < 0.01). Patients in the control group did not demonstrate any significant change in ADL scores (P > 0.05) during the entire course of the treatment.»
